Baroda BNP Paribas Health and Wellness Fund
The fund maintains a heavily pharma-centric positioning with two-thirds of assets in drugs and biotech, expecting sustained demand from India's aging population and rising healthcare spending. The manager's conviction shifted meaningfully this month—trimming a large hospital operator to upgrade pure-play pharma exposure and adding specialty drugmakers like Concord Biotech and Cohance, signaling confidence in high-margin segments over diversified healthcare conglomerates. With over half the portfolio in just ten stocks, returns hinge significantly on a narrow set of pharmaceutical winners.
Portfolio analysis · April 2026
NAV & Returns
| Plan | NAV | 1M | 3M | 6M | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|---|---|
| Primary | ₹9.7547 | +5.66% | +4.57% | +0.95% | — | — | — |
Portfolio Metrics(latest month)
What Changed2026-03-31 → 2026-04-30
| Stock | Weight |
|---|---|
| Concord Biotech Limited | 1.29% |
| Procter & Gamble Health Limited | 1.08% |
| Max Financial Services Limited | 1.05% |
| Cohance Lifesciences Limited | 0.96% |
Full Holdings
| # | Holding | % to NAV |
|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited INE044A01036 | 9.38% |
| 2 | Lupin Limited INE326A01037 | 6.09% |
| 3 | IPCA Laboratories Limited INE571A01038 | 5.34% |
| 4 | Abbott India Limited INE358A01014 | 5.28% |
| 5 | Torrent Pharmaceuticals Limited INE685A01028 | 5.13% |
| 6 | Laurus Labs Limited INE947Q01028 | 4.78% |
| 7 | Fortis Healthcare Limited INE061F01013 | 4.35% |
| 8 | Apollo Hospitals Enterprise Limited INE437A01024 | 4.32% |
| 9 | JB Chemicals & Pharmaceuticals Limited INE572A01036 | 4.24% |
| 10 | AstraZeneca Pharma India Limited INE203A01020 | 4.03% |
| 11 | Emcure Pharmaceuticals Limited INE168P01015 | 3.44% |
| 12 | SBI Life Insurance Company Limited INE123W01016 | 3.43% |
| 13 | Aster DM Healthcare Limited INE914M01019 | 2.97% |
| 14 | Clearing Corporation of India Ltd nan | 2.88% |
| 15 | ICICI Prudential Life Insurance Company Limited INE726G01019 | 2.81% |
| 16 | Glenmark Pharmaceuticals Limited INE935A01035 | 2.72% |
| 17 | Aurobindo Pharma Limited INE406A01037 | 2.62% |
| 18 | Dr. Lal Path Labs Limited INE600L01024 | 2.58% |
| 19 | Gland Pharma Limited INE068V01023 | 2.09% |
| 20 | Divi's Laboratories Limited INE361B01024 | 2.07% |
Sector Allocation
Top 10 sectors by % to NAV. Excludes derivatives.